Skip to content
Menu

Cullinan Therapeutics, Inc. CGEM

Full chart Compare
Set alert

Price alert · CGEM

All alert types
8.89 USD -0.18 (-1.98%)

Regular-session close

8.96 +0.07 +0.79%

After hours · Nov 20, 7:38 PM ET

8.80 Day range 9.43
8.72 52-week range 22.95
YTD
-14.11%
1 year
+1.95%

Revenue & Expenses

Revenue Profit Costs
Other Income$2.38MGross Profit$18.94MNet Loss$65.57MExpenses$86.90MSelling, General & Admin$29.15MResearch & Development$57.75MRevenue$18.94M

Latest period ending Dec 31, 2025 · select a line to chart its full history

CGEM annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-241.65M-196.92M-191.09M144.65M-67.95M
-219.88M-167.38M-153.16M111.21M-65.57M
-3.36-2.78-3.212.38-1.52
CGEM annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
88.33M83.00M98.43M156.15M59.77M
448.37M621.82M484.18M561.12M437.19M
39.64M31.50M30.29M26.09M11.81M
2.68M2.15M3.59M5.01M0
408.73M590.33M453.70M535.03M424.97M
CGEM annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-175.75M-145.30M-134.28M-126.66M-43.43M
179.99M-136.31M35.81M248.97M-333.77M
1.09M266.19M40.75M-25.93M268.78M
-49.00K0-208.00K-1.04M0
5.33M-15.43M-57.72M96.38M-108.42M